• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pirfenidone-Induced Lichenoid Drug Eruption in a Patient with Idiopathic Lung Fibrosis.

作者信息

Jeong In Jae, Lee Hee Jung, Yoon Moon Soo, Kim Dong Hyun

机构信息

Department of Dermatology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea.

出版信息

Ann Dermatol. 2019 Feb;31(1):103-105. doi: 10.5021/ad.2019.31.1.103. Epub 2019 Jan 2.

DOI:10.5021/ad.2019.31.1.103
PMID:33911552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7992701/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cc/7992701/e7aa32dde549/ad-31-103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cc/7992701/e9b50f368ddf/ad-31-103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cc/7992701/e7aa32dde549/ad-31-103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cc/7992701/e9b50f368ddf/ad-31-103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5cc/7992701/e7aa32dde549/ad-31-103-g002.jpg

相似文献

1
Pirfenidone-Induced Lichenoid Drug Eruption in a Patient with Idiopathic Lung Fibrosis.吡非尼酮诱发的特发性肺纤维化患者苔藓样药疹。
Ann Dermatol. 2019 Feb;31(1):103-105. doi: 10.5021/ad.2019.31.1.103. Epub 2019 Jan 2.
2
Pirfenidone-induced photoleukomelanoderma in a patient with idiopathic pulmonary fibrosis.吡非尼酮诱发的特发性肺纤维化患者光化性白黑皮病
J Dermatol. 2016 Feb;43(2):207-9. doi: 10.1111/1346-8138.13009. Epub 2015 Jun 29.
3
Clonazepam-induced lichenoid drug eruption: a case report.氯硝西泮诱导的苔藓样药物疹：一例报告。
BMC Psychiatry. 2021 Mar 4;21(1):125. doi: 10.1186/s12888-021-03132-2.
4
Upregulation of RGS2: a new mechanism for pirfenidone amelioration of pulmonary fibrosis.RGS2的上调：吡非尼酮改善肺纤维化的新机制。
Respir Res. 2016 Aug 22;17(1):103. doi: 10.1186/s12931-016-0418-4.
5
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.吡非尼酮治疗特发性肺纤维化（CAPACITY）患者的两项随机试验。
Lancet. 2011 May 21;377(9779):1760-9. doi: 10.1016/S0140-6736(11)60405-4. Epub 2011 May 13.
6
Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.卵磷脂-超氧化物歧化酶和/或吡非尼酮对博来霉素诱导的肺纤维化的影响。
Chest. 2012 Oct;142(4):1011-1019. doi: 10.1378/chest.11-2879.
7
Atorvastatin-induced Lichenoid Drug Eruption: A Case Report and Review of Statin-associated Cutaneous Adverse Events.阿托伐他汀诱发的苔藓样药疹：一例病例报告及他汀类药物相关皮肤不良事件综述
Cureus. 2020 Mar 1;12(3):e7155. doi: 10.7759/cureus.7155.
8
A phase II trial evaluating the efficacy and safety of perioperative pirfenidone for prevention of acute exacerbation of idiopathic pulmonary fibrosis in lung cancer patients undergoing pulmonary resection: West Japan Oncology Group 6711 L (PEOPLE Study).一项评估围手术期使用吡非尼酮预防接受肺切除术的肺癌患者特发性肺纤维化急性加重的疗效和安全性的II期试验：日本西部肿瘤学组6711L（PEOPLE研究）。
Respir Res. 2016 Jul 22;17(1):90. doi: 10.1186/s12931-016-0398-4.
9
Pharmacokinetic evaluation of tissue distribution of pirfenidone and its metabolites for idiopathic pulmonary fibrosis therapy.吡非尼酮及其代谢产物在特发性肺纤维化治疗中的组织分布药代动力学评价。
Biopharm Drug Dispos. 2015 May;36(4):205-15. doi: 10.1002/bdd.1932. Epub 2015 Feb 1.
10
Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.吡非尼酮和泼尼松龙的抗纤维化作用：对博来霉素诱导的小鼠肺纤维化中肺细胞因子和生长因子的不同影响
Eur J Pharmacol. 2008 Aug 20;590(1-3):400-8. doi: 10.1016/j.ejphar.2008.06.046. Epub 2008 Jun 16.

引用本文的文献

1
A Case of Pirfenidone-Induced Photosensitive Drug Eruption.一例吡非尼酮诱发的光敏性药疹病例。
Ann Dermatol. 2023 May;35(Suppl 1):S48-S51. doi: 10.5021/ad.21.052.
2
A Case Report of Pirfenidone-Induced Lichenoid Drug Eruption in a Patient with Idiopathic Pulmonary Fibrosis.一例特发性肺纤维化患者服用吡非尼酮后发生苔藓样药疹的病例报告
Ann Dermatol. 2022 Apr;34(2):136-138. doi: 10.5021/ad.2022.34.2.136. Epub 2022 Mar 24.

本文引用的文献

1
Photosafety assessments on pirfenidone: photochemical, photobiological, and pharmacokinetic characterization.吡非尼酮的光安全性评估：光化学、光生物学和药代动力学特征。
J Photochem Photobiol B. 2013 Mar 5;120:44-51. doi: 10.1016/j.jphotobiol.2013.01.010. Epub 2013 Jan 29.
2
Adverse events of pirfenidone for the treatment of pulmonary fibrosis: a meta-analysis of randomized controlled trials.吡非尼酮治疗肺纤维化的不良反应：一项随机对照试验的荟萃分析。
PLoS One. 2012;7(10):e47024. doi: 10.1371/journal.pone.0047024. Epub 2012 Oct 9.
3
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
吡非尼酮治疗特发性肺纤维化（CAPACITY）患者的两项随机试验。
Lancet. 2011 May 21;377(9779):1760-9. doi: 10.1016/S0140-6736(11)60405-4. Epub 2011 May 13.
4
A florid rash during summer. Photodistributed lichenoid drug eruption (LDE) secondary to quinine.夏季出现的皮疹。继发于奎宁的光分布性苔藓样药疹（LDE）。
Clin Exp Dermatol. 2010 Apr;35(3):e83-4. doi: 10.1111/j.1365-2230.2009.03538.x.
5
Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists.扁平苔藓样皮疹：肿瘤坏死因子-α拮抗剂的一种新出现的副作用。
J Am Acad Dermatol. 2009 Jul;61(1):104-11. doi: 10.1016/j.jaad.2008.09.032.